A team of scientists from the San Raffaele-Telethon Institute for Gene Therapy (SR-Tiget) in Milan, Italy, has identified a ...

FDA places clinical hold of RP-A501 for the treatment of patients with Danon disease due to a patient death. Click here to ...

H.C. Wainwright reaffirmed its Buy rating on BioLife Solutions, Inc. (NASDAQ:BLFS) while keeping the price target the same at ...

Successful trial results in the next few years could save thousands of lives and generate billions in new annual revenue for ...

Regulators will review data on satri-cel's ability to treat advanced Claudin18.2-positive tumors in an expedited timeline.